NanoVibronix, Inc.
NAOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $4 | $9 | $21 |
| - Cash | $7 | $4 | $1 | $1 |
| + Debt | $0 | $2 | $4 | $0 |
| Enterprise Value | -$4 | $3 | $13 | $20 |
| Revenue | $1 | $0 | $1 | $0 |
| % Growth | 46.2% | -51.8% | 130.9% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 26.2% | -7.1% | 36% | 63.7% |
| EBITDA | $1 | -$3 | -$2 | -$1 |
| % Margin | 118.4% | -688.5% | -235% | -313.5% |
| Net Income | $1 | -$0 | -$2 | -$1 |
| % Margin | 70.6% | -31.6% | -243.4% | -322.3% |
| EPS Diluted | 1.05 | -1.03 | -3.98 | -4.21 |
| % Growth | 201.9% | 74.1% | 5.5% | – |
| Operating Cash Flow | -$2 | -$3 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$3 | -$1 | -$1 |